These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6732230)
1. Azlocillin pharmacokinetics in patients with cystic fibrosis. Bosso JA; Saxon BA; Herbst JJ; Matsen JM Antimicrob Agents Chemother; 1984 May; 25(5):630-2. PubMed ID: 6732230 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of azlocillin in children with cystic fibrosis. Bergan T; Michalsen H Arzneimittelforschung; 1979; 29(12a):1955-7. PubMed ID: 543899 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of high-dose azlocillin sodium in patients with cystic fibrosis. Woolf RA; Koup JR; Smith AL; Hilman BC; Goldmann D; Williams-Warren J Clin Pharm; 1985; 4(6):664-9. PubMed ID: 4075734 [TBL] [Abstract][Full Text] [Related]
4. Serum and sputum concentrations of azlocillin, cefoperazone and ceftazidime in patients with cystic fibrosis. Martini N; Agostini M; Barlocco G; Bozzini L; Castellani L; Messori A; Scroccaro G; Mastella G J Clin Hosp Pharm; 1984 Dec; 9(4):303-9. PubMed ID: 6396321 [TBL] [Abstract][Full Text] [Related]
5. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency. Bergan T J Antimicrob Chemother; 1983 May; 11 Suppl B():101-14. PubMed ID: 6352598 [TBL] [Abstract][Full Text] [Related]
6. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis. Michalsen H; Bergan T Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708 [TBL] [Abstract][Full Text] [Related]
7. [Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies]. Modr Z; Dvorácek K; Janků I; Krebs V Infection; 1982; 10 Suppl 3():S184-90. PubMed ID: 7152688 [TBL] [Abstract][Full Text] [Related]
8. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis]. Grenier B; Gilly R Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602 [TBL] [Abstract][Full Text] [Related]
9. [Azlocillin in the treatment of pulmonary infections in patients with cystic fibrosis: plasma concentrations and therapeutic indications]. Rosselli P; Marianelli L; Valenza T; Bartolozzi G Pediatr Med Chir; 1989; 11(4):389-91. PubMed ID: 2694104 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients]. Fillastre JP; Humbert G; Leroy A; Godin M Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597 [TBL] [Abstract][Full Text] [Related]
11. Azlocillin in cystic fibrosis. Malmborg AS; Alfredsson H; Strandvik B Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of azlocillin in children with and without cystic fibrosis treated for infectious diseases. Michalsen H; Bergan T Methods Find Exp Clin Pharmacol; 1986 Dec; 8(12):727-9. PubMed ID: 3807473 [TBL] [Abstract][Full Text] [Related]
18. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis. Michalsen H; Bergan T Scand J Infect Dis Suppl; 1981; 29():92-7. PubMed ID: 6947408 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin. Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and clinical aspects of azlocillin in paediatrics. Heimann G J Antimicrob Chemother; 1983 May; 11 Suppl B():127-35. PubMed ID: 6619022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]